Skip to main
HR

HR Stock Forecast & Price Target

HR Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 11%
Buy 33%
Hold 56%
Sell 0%
Strong Sell 0%

Bulls say

Healthcare Realty Trust is well-positioned to benefit from the steady movement towards outpatient care and its relatively low credit risk in the medical office sector. The company's IFRS NAVPU and equity value both saw minor declines but were in line with expectations. HR's leverage also improved significantly, and its liquidity increased, providing the company with flexibility for future growth opportunities. While HR may not have the same growth potential as other sectors, its steady mid-single-digit growth and strong credit risk profile make it a compelling investment in the healthcare REIT sector.

Bears say

Healthcare Realty Trust is facing significant challenges in its operations, with a decline in occupancy and same-asset cash NOI growth, as well as slower performance from its Lantower properties and a decrease in lease spreads. This trend is likely to continue in the near future, potentially resulting in a decrease in value for the company and its stock. Additionally, the company's focus on stable, repeatable cash flow rather than high growth could limit its potential for strong stock performance in the long term. Finally, changes in market conditions, such as an increase in medical office cap rates, could further impact the company's stock performance.

HR has been analyzed by 9 analysts, with a consensus rating of Buy. 11% of analysts recommend a Strong Buy, 33% recommend Buy, 56% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Healthcare Realty Trust Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Healthcare Realty Trust Inc (HR) Forecast

Analysts have given HR a Buy based on their latest research and market trends.

According to 9 analysts, HR has a Buy consensus rating as of Jun 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Healthcare Realty Trust Inc (HR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.